Complete Tophus Response in Patients with Chronic Gout Initiating Pegloticase Treatment

被引：0
|
作者：
Becker, Michael A. [2 ]
Gonter, Neil J. [1 ]
Pope, Janet E. [3 ]
Malamet, Raymond L. [4 ]
Baraf, Herbert S. B. [5 ]
机构：
[1] Rheumatol Associates N Jersey, Teaneck, NJ USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Western Ontario, London, ON, Canada
[4] Savient Pharmaceut Inc, E Brunswick, NJ USA
[5] Arthrit & Rheumatism Associates, Wheaton, MD USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1913
引用
收藏
页码：S812 / S812
页数：1
相关论文
共 50 条
  • [31] Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
    Karim Richard Masri
    Lissa Padnick-Silver
    Kevin Winterling
    Brian LaMoreaux
    Rheumatology and Therapy, 2022, 9 : 555 - 563
  • [32] Pharmacokinetics and Immunogenicity of Pegloticase in Patients With Kidney Transplants Receiving Pegloticase for Uncontrolled Gout
    Abdellatif, Abdul A.
    Xin, Yan
    Chamberlain, Jason
    Zhao, Lin
    Cherny, Katya
    Marder, Brad A.
    Scandling, John D.
    Saag, Kenneth G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 390 - 390
  • [33] PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT OF METHOTREXATE
    Song, Y.
    Xin, Y.
    Weinblatt, M. E.
    Chamberlain, J.
    Obermeyer, K.
    Zhao, L.
    Canavan, C.
    Peloso, P. M.
    Ramanathan, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 847 - 848
  • [34] PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT WITH METHOTREXATE
    Xin, Y.
    Song, Y.
    Weinblatt, M. E.
    Chamberlain, J.
    Zarzoso, J.
    Obermeyer, K.
    Sainati, S.
    Canavan, C.
    Ramanathan, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 910 - 910
  • [35] Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
    Masri, Karim Richard
    Padnick-Silver, Lissa
    Winterling, Kevin
    LaMoreaux, Brian
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 555 - 563
  • [36] Giant tophus in the course of gout, with a good response to infliximab
    Chiriac, A.
    Chiriac, A. E.
    Foia, L.
    Pinteala, T.
    Brzezinski, P.
    ARCHIVES OF HELLENIC MEDICINE, 2014, 31 (02): : 218 - 220
  • [37] Pegloticase reduces serum urate levels in patients with treatment-refractory gout
    Nature Clinical Practice Rheumatology, 2008, 4 (12): : 624 - 624
  • [38] Pegloticase: A Novel Agent for Treatment-Refractory Gout
    Shannon, Jennifer A.
    Cole, Sabrina W.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 368 - 376
  • [39] EVIDENCE BASED DEVELOPMENT OF CRITERIA FOR COMPLETE RESPONSE IN PATIENTS WITH CHRONIC REFRACTORY GOUT
    Schlesinger, N.
    Khanna, P.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 377 - 378
  • [40] Initial Pegloticase Serum Levels Predict Persistent Responsiveness in Patients with Chronic Refractory Gout
    Saag, Kenneth
    Feinman, Mitchell
    Baraf, Herbert S. B.
    Fleischmann, Roy
    Kavanaugh, Arthur
    Lipsky, Peter E.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345